Home  »  Finance   »  Looking For A Top Momentum Stock? Why AnaptysBio I...

Looking For A Top Momentum Stock? Why AnaptysBio Inc. (NASDAQ: ANAB) Is A Great Pick

AnaptysBio Inc. (NASDAQ:ANAB) shares, rose in value on Friday, 05/13/22, with the stock price down by -0.38% to the previous day’s close as strong demand from buyers drove the stock to $21.13.

Actively observing the price movement in the last trading, the stock closed the session at $21.21, falling within a range of $20.24 and $21.60. The value of beta (5-year monthly) was 0.15. Referring to stock’s 52-week performance, its high was $37.89, and the low was $20.56. On the whole, ANAB has fluctuated by -12.32% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.


With the market capitalization of AnaptysBio Inc. currently standing at about $568.19 million, investors are eagerly awaiting this quarter’s results, scheduled for May 02, 2022 – May 06, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $2.57, which is expected to increase to -$0.31 for fiscal year $0.83 and then to about -$3.26 by fiscal year 2022. Data indicates that the EPS growth is expected to be 213.70% in 2022, while the next year’s EPS growth is forecast to be -492.80%.

According to the average forecast, sales growth in current quarter could jump up 84.80%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2022, the company’s y-o-y revenues would reach $149.61 million, representing an increase of 99.50% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that ANAB’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 50% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of ANAB currently trading nearly -6.87% and -15.64% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.78, while the 7-day volatility ratio is showing 6.96% which for the 30-day chart, stands at 6.57%. Furthermore, AnaptysBio Inc. (ANAB)’s beta value is 0.15, and its average true range (ATR) is 1.50.

A comparison of AnaptysBio Inc. (ANAB) with its peers suggests the former has fared considerably weaker in the market. ANAB showed an intraday change of -0.38% in last session, and over the past year, it shrunk by -19.04%%. In comparison, Molecular Templates Inc. (MTEM) has moved higher at 5.08% on the day and was down -84.22% over the past 12 months. Other than that, the overall performance of the S&P 500 during the last trading session shows that it gained 2.39%. Meanwhile, the Dow Jones Industrial Improved by 1.47%.

Data on historical trading for AnaptysBio Inc. (NASDAQ:ANAB) indicates that the trading volumes over the past 10 days have averaged 0.56 million and over the past 3 months, they’ve averaged 269.12K. According to company’s latest data on outstanding shares, there are 27.71 million shares outstanding.

The data on short interest also indicates that stock shorts accounted for 2.29 million shares as on Dec 14, 2021, resulting in a short ratio of 14.42. According to the data, the short interest in AnaptysBio Inc. (ANAB) stood at 8.34% of shares outstanding as of Dec 14, 2021; the number of short shares registered in Nov 14, 2021 reached 2.33 million. The stock has fallen by -39.19% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ANAB stock heading into the next quarter.

Leave a Comment

Your email address will not be published.

Related Videos

Related Posts



Download Free eBook For


100% free. stop anytime no spam